Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ernexa Therapeutics (ERNA) FCF Payout Ratio (2016 - 2023)

Historic FCF Payout Ratio for Ernexa Therapeutics (ERNA) over the last 7 years, with Q4 2023 value amounting to 0.0.

  • Ernexa Therapeutics' FCF Payout Ratio fell 1658.12% to 0.0 in Q4 2023 from the same period last year, while for Sep 2024 it was 0.0, marking a year-over-year change of. This contributed to the annual value of 0.0 for FY2023, which is 414.16% down from last year.
  • According to the latest figures from Q4 2023, Ernexa Therapeutics' FCF Payout Ratio is 0.0, which was down 1658.12% from 0.0 recorded in Q4 2022.
  • Ernexa Therapeutics' FCF Payout Ratio's 5-year high stood at 0.01 during Q4 2019, with a 5-year trough of 0.0 in Q4 2023.
  • Over the past 4 years, Ernexa Therapeutics' median FCF Payout Ratio value was 0.0 (recorded in 2022), while the average stood at 0.0.
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first tumbled by 4553.29% in 2020, then crashed by 1658.12% in 2023.
  • Quarter analysis of 4 years shows Ernexa Therapeutics' FCF Payout Ratio stood at 0.01 in 2019, then plummeted by 45.53% to 0.0 in 2020, then plummeted by 130.25% to 0.0 in 2022, then dropped by 16.58% to 0.0 in 2023.
  • Its FCF Payout Ratio was 0.0 in Q4 2023, compared to 0.0 in Q4 2022 and 0.0 in Q4 2020.